MCID: SDD001
MIFTS: 61

Sudden Infant Death Syndrome malady

Categories: Genetic diseases, Rare diseases

Aliases & Classifications for Sudden Infant Death Syndrome

About this section

Aliases & Descriptions for Sudden Infant Death Syndrome:

Name: Sudden Infant Death Syndrome 52 11 48 70 27 50 38 2 13 68
Sids 11 48 70 2
Sudden Infant Death Syndrome, Susceptibility to 12
Sudden Death of Nonspecific Cause in Infancy 11
 
Sudden Infant Death Syndrome Nos 11
Sudden Infant Death 39
Crib Death 11
Cot Death 11

Characteristics:

HPO:

64
sudden infant death syndrome:
Mortality/Aging: sudden death

Classifications:



External Ids:

OMIM52 272120
Disease Ontology11 DOID:9007
ICD9CM32 798.0
MeSH39 D013398
NCIt45 C85173
MedGen37 C0038644
ICD1030 R95

Summaries for Sudden Infant Death Syndrome

About this section
MedlinePlus:38 Sudden infant death syndrome (sids) is the sudden, unexplained death of an infant younger than one year old. some people call sids "crib death" because many babies who die of sids are found in their cribs. sids is the leading cause of death in children between one month and one year old. most sids deaths occur when babies are between one month and four months old. premature babies, boys, african americans, and american indian/alaska native infants have a higher risk of sids. although health care professionals don't know what causes sids, they do know ways to reduce the risk. these include placing your baby on his or her back to sleep, even for short naps. "tummy time" is for when babies are awake and someone is watching having your baby sleep in your room for at least the first six months. your baby should sleep close to you, but on a separate surface designed for infants, such as a crib or bassinet. using a firm sleep surface, such as a crib mattress covered with a fitted sheet keeping soft objects and loose bedding away from your baby's sleep area breastfeeding your baby making sure that your baby doesn't get too hot. keep the room at a comfortable temperature for an adult. not smoking during pregnancy or allowing anyone to smoke near your baby nih: national institute of child health and human development

MalaCards based summary: Sudden Infant Death Syndrome, also known as sids, is related to sudden infant death with dysgenesis of the testes syndrome and cav3-related sudden infant death syndrome, and has symptoms including apneic episodes in infancy, disturbance of thermoregulation of newborn and disturbance of thermoregulation of newborn. An important gene associated with Sudden Infant Death Syndrome is SCN5A (Sodium Voltage-Gated Channel Alpha Subunit 5), and among its related pathways are Biogenic Amine Synthesis and Sympathetic Nerve Pathway (Pre- and Post- Ganglionic Junction). Affiliated tissues include brain, skin and heart, and related mouse phenotypes are muscle and cardiovascular system.

Disease Ontology:11 A syndrome that is characterized by the sudden death of an infant that is not predicted by medical history and remains unexplained after a thorough forensic autopsy and detailed death scene investigation.

NIH Rare Diseases:48 Sudden infant death syndrome (SIDS) is the unexpected, sudden death of a child under age 1 which cannot be explained after a thorough investigation is conducted. Infants who are affected by the condition generally appear healthy with no suspicious signs and symptoms prior to the incident. It is the leading cause of death in infants age 1 to 12 months old. The exact underlying cause of SIDS is unknown; however, scientists suspect that it is likely a multifactorial condition (associated with the effects of multiple genes in combination with lifestyle and environmental factors). Although there is no guaranteed way to prevent SIDS, the American Academy of Pediatrics has a published list of recommendations for risk reduction. Please click on the link to access this resource. Last updated: 12/15/2015

OMIM:52 Sudden infant death syndrome (SIDS) is a diagnosis of exclusion which should be made only after a thorough autopsy... (272120) more...

UniProtKB/Swiss-Prot:70 Sudden infant death syndrome: SIDS is the sudden death of an infant younger than 1 year that remains unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of clinical history. Pathophysiologic mechanisms for SIDS may include respiratory dysfunction, cardiac dysrhythmias, cardiorespiratory instability, and inborn errors of metabolism, but definitive pathogenic mechanisms precipitating an infant sudden death remain elusive.

Wikipedia:71 Sudden infant death syndrome (SIDS), also known as cot death or crib death, is the sudden unexplained... more...

Related Diseases for Sudden Infant Death Syndrome

About this section

Diseases in the Sudden Infant Death Syndrome family:

Cav3-Related Sudden Infant Death Syndrome

Diseases related to Sudden Infant Death Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 77)
idRelated DiseaseScoreTop Affiliating Genes
1sudden infant death with dysgenesis of the testes syndrome12.7
2cav3-related sudden infant death syndrome12.2
3reye syndrome11.2
4infantile apnea11.2
5infantile histiocytoid cardiomyopathy11.0
6hyperekplexia, hereditary 1, autosomal dominant or recessive10.9
7brugada syndrome 210.7GPD1L, SCN5A
8submucous uterine fibroid10.7GPD1L, SCN2B, SCN5A
9dissociative disorder10.6IDS, SLC6A4
10todd's paralysis10.6KCNH2, KCNQ1, SCN5A
11microcephaly-polymicrogyria-corpus callosum agenesis syndrome10.6KCNH2, KCNQ1, SCN5A
12acute tricyclic antidepressant poisoning10.6KCNH2, KCNQ1
13brugada syndrome 110.6KCNH2, SCN5A
14cone dystrophy10.6KCNH2, KCNQ1, SCN5A
15second-degree atrioventricular block10.6KCNH2, KCNQ1, SCN5A
16prostate malignant phyllodes tumor10.6KCNH2, KCNQ1, SCN5A
17atrial fibrillation, familial, 310.6CAV3, KCNH2, KCNQ1, SCN5A
18sult4a1-related altered drug metabolism10.6KCNH2, KCNQ1, SCN5A, SNTA1
19jervell and lange-nielsen syndrome10.5CAV3, KCNH2, KCNQ1, SCN5A, SNTA1
20cardiac conduction disease with or without dilated cardiomyopathy10.5KCNH2, KCNQ1
21melancholia10.5CAV3, KCNH2, KCNQ1, SCN5A, SNTA1
22chicken egg allergy10.3MT-ND1, SCN5A, SNTA1
23adams-oliver syndrome10.3KCNQ1, SCN2B, SCN5A
24neuronitis10.2
25hypoxia10.2
26gingival disease10.1CHAT, TH
27parkinson disease, late-onset10.1ADCYAP1, CHAT, MT-ND1, SLC6A4, TH
28laryngitis10.0
29infant botulism10.0
30cerebritis9.9
31hypophosphatemia9.8
32toxic shock syndrome9.8
33pneumonia9.8
34myocarditis9.8
35asthma9.6
36orthostatic intolerance9.6
37ectodermal dysplasia9.6
38hepatitis9.6
39brugada syndrome9.6
40fetal alcohol syndrome9.6
41short qt syndrome9.6
42sleep apnea9.6
43munchausen by proxy9.6
44cardiac arrest9.6
45legionellosis9.6
46nasopharyngitis9.6
47pertussis9.6
48respiratory failure9.6
49tetanus9.6
50diphtheria9.6

Graphical network of the top 20 diseases related to Sudden Infant Death Syndrome:



Diseases related to sudden infant death syndrome

Symptoms & Phenotypes for Sudden Infant Death Syndrome

About this section

Symptoms by clinical synopsis from OMIM:

272120

Clinical features from OMIM:

272120

Human phenotypes related to Sudden Infant Death Syndrome:

 64
id Description HPO Frequency HPO Source Accession
1 apneic episodes in infancy64 HP:0005949

UMLS symptoms related to Sudden Infant Death Syndrome:


disturbance of thermoregulation of newborn

MGI Mouse Phenotypes related to Sudden Infant Death Syndrome according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053699.9ACADM, ADCYAP1, CAV3, CHAT, EN1, KCNH2
2MP:00053859.8ACADM, CAV3, CHAT, EN1, KCNH2, KCNJ8
3MP:00053869.6ADCYAP1, CHAT, EN1, FEV, IDS, KCNQ1
4MP:00107689.6ACADM, ADCYAP1, CHAT, EN1, FEV, IDS
5MP:00053769.5ACADM, ADCYAP1, CAV3, CHAT, EN1, FEV
6MP:00036318.7ADCYAP1, CHAT, EN1, FEV, IDS, KCNQ1

Drugs & Therapeutics for Sudden Infant Death Syndrome

About this section

Drugs for Sudden Infant Death Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
NicotineapprovedPhase 4, Phase 2105054-11-5942, 89594
Synonyms:
(−
(+)-Nicotine
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(-)-Nicotine
(-)-Nicotine solution
(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE
(S)-(-)-Nicotine
(S)-(−)-nicotine
(S)-3-(1-methylpyrrolidin-2-yl)pyridine
(S)-3-(N-methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
(−)-nicotine
)-1-Methyl-2-(3-pyridyl)pyrrolidine
)-Nicotine
)-Nicotine solution
1-Methyl-2-(3-pyridal)-Pyrrolidine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
1uw6
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-Pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-(N-methylpyrollidino)pyridine
3-N-Methylpyrrolidine
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
36733_FLUKA
36733_RIEDEL
434F7990-3240-4A43-ACEC-E6CC1E495FA0
46343_FLUKA
46343_RIEDEL
54-11-5
AC1L3I79
AC1Q3ZOC
AI3-03424
BB_NC-0777
BIDD:GT0599
BRD-K05395900-322-02-1
Black Leaf
Black Leaf 40
C00745
CCRIS 1637
CHEBI:17688
CHEMBL3
CID89594
CPD000059074
Campbell's Nico-Soap
Caswell No. 597
Commit
D-Nicotine
D03365
DL-tetrahydronicotyrine
Destruxol
Destruxol Orchid Spray
EINECS 200-193-3
ENT 3,424
EPA Pesticide Chemical Code 056702
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
HSDB 1107
Habitrol
Habitrol (TN)
L(-)-nicotine
L(−)-nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
 
L-Nicotine
LS-202
MLS001055457
MLS001335905
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Micotine
MolPort-000-744-731
N3876_SIGMA
N5511_FLUKA
N5511_SIGMA
NCGC00090693-01
NCGC00090693-02
NCGC00090693-03
NCGC00090693-04
NCGC00090693-05
NCGC00090693-06
NCGC00090693-07
NCT
NICOTINE AND SALTS
NSC 5065
NSC97238
Niagara P.A. Dust
Nic-Sal
Nico-Dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm Cq
Nicoderm Patch
Nicorette
Nicorette Plus
Nicotin
Nicotina
Nicotina [Italian]
Nicotine
Nicotine (USP)
Nicotine (compounds related to)
Nicotine Alkaloid
Nicotine Patch
Nicotine Polacrilex
Nicotine [BSI:ISO]
Nicotine [UN1654]
Nicotine [UN1654] [Poison]
Nicotine [USAN]
Nicotrol
Nicotrol Inhaler
Nicotrol Ns
Nictoine patch
Nikotin
Nikotin [German]
Nikotyna
Nikotyna [Polish]
Ortho N-4 Dust
Ortho N-5 Dust
PDSP1_000113
PDSP1_000465
PDSP2_000463
PDSP2_000555
Prostep
R)-(+)-Nicotine
RCRA waste no. P075
RCRA waste number P075
SAM002564224
SDCCGMLS-0066911.P001
SMR000059074
Tendust
Transdermal Nicotine
UN1654
a -N-Methylpyrrolidine
a-N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methyl pyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
bmse000105
delta-Nicotine
nicotine
nicotine replacement patch
2
LabetalolapprovedPhase 2, Phase 3, Phase 13436894-69-63869
Synonyms:
2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide
2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide
2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide
3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
36894-69-6
5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
AB00053659
AC-18747
AC1L1GW8
AH 5158
AH-5158
Albetol
BPBio1_000170
BRD-A07440155-003-05-6
BSPBio_000154
BSPBio_003142
C07063
CHEBI:6343
CHEMBL429
CID3869
D08106
DB00598
DivK1c_000474
EINECS 253-258-3
HSDB 6537
IDI1_000474
Ibidomide
KBio1_000474
KBio2_002087
KBio2_004655
KBio2_007223
 
KBio3_002642
KBioGR_000727
KBioSS_002087
L001344
LS-26936
Labetalol
Labetalol (INN)
Labetalol [INN:BAN]
Labetalolum
Labetalolum [INN-Latin]
Labetolol
Lopac0_000687
MolPort-003-898-140
NCGC00015595-06
NCGC00089800-02
NINDS_000474
NORMOZIDE
Prestwick0_000277
Prestwick1_000277
Prestwick2_000277
Prestwick3_000277
SBB067266
SPBio_000905
SPBio_002373
Sch-19927
Spectrum2_000863
Spectrum3_001581
Spectrum4_000184
Spectrum5_001010
Spectrum_001607
TL8002725
UNII-R5H8897N95
labetalol
3Calcium, DietaryPhase 2, Phase 3, Phase 15525
4Neurotransmitter AgentsPhase 2, Phase 3, Phase 117734
5Peripheral Nervous System AgentsPhase 2, Phase 3, Phase 122776
6Tocolytic AgentsPhase 2, Phase 3, Phase 1708
7Autonomic AgentsPhase 2, Phase 3, Phase 19774
8calcium channel blockersPhase 2, Phase 3, Phase 11940
9Antihypertensive AgentsPhase 2, Phase 3, Phase 14095
10Adrenergic alpha-1 Receptor AntagonistsPhase 2, Phase 3, Phase 1470
11Adrenergic AgentsPhase 2, Phase 3, Phase 15140
12Adrenergic AntagonistsPhase 2, Phase 3, Phase 11535
13Adrenergic alpha-AntagonistsPhase 2, Phase 3, Phase 1727
14Adrenergic beta-AntagonistsPhase 2, Phase 3, Phase 11154
15AnalgesicsPhase 2, Phase 3, Phase 111287
16
ClonidineapprovedPhase 1, Phase 22264205-90-72803
Synonyms:
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2,6-dichloro-N-(2-imidazolidinylidene)aniline
2,6-dichloro-N-2-imidazolidinylidenebenzenamide
2,6-dichloro-N-imidazolidin-2-ylideneaniline
2-((2,6-Dichlorophenyl)imino)imidazolidine
2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)
2-(2,6-Dichloroanilino)-2-imidazoline
2-(2,6-Dichlorophenylamino)-2-imidazoline
2-(2,6-Dichlorophenylimino)imidazolidine
2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)
2-[(2,6-Dichlorophenyl)imino]imidazoline
2-[(2,6-dichlorophenyl)imino]-2-imidazoline
4205-90-7
4205-91-8 (mono-hydrochloride)
57066-25-8
734571A
AB00514634
AC1L1EI5
AC1Q3K6V
AKOS001595470
Adesipress
BIDD:GT0547
BPBio1_000040
BRD-K98530306-001-02-1
BRD-K98530306-003-05-0
BSPBio_000036
BSPBio_001588
BSPBio_002055
Bio1_000470
Bio1_000959
Bio1_001448
Bio2_000308
Bio2_000788
C9H9Cl2N3
CAS-4205-91-8
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
CCRIS 7787
CHEBI:3757
CHEBI:46632
CHEMBL134
CID2803
Catapres
Catapres- TTS
Catapres-TTS
Catapresan
Catapressan
Catarpres
Catarpres-TTS
Catarpres-TTS (TN)
Catarpresan
Chlofazoline
Chlornidinum
Clofenil
Clonidin
Clonidina
Clonidina [INN-Spanish]
Clonidine (JAN/USAN/INN)
Clonidine HCl
Clonidine [USAN:BAN:INN]
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
D00281
DB00575
DB07566
DivK1c_000774
 
Dixarit
Duraclon
Duraclont
EINECS 224-119-4
Gemiton
HMS1361P10
HMS1791P10
HMS1989P10
HMS2089G11
HSDB 3040
Hemiton
IDI1_000774
IDI1_034058
Ipotensium
Isoglaucon
KBio1_000774
KBio2_000308
KBio2_001821
KBio2_002876
KBio2_004389
KBio2_005444
KBio2_006957
KBio3_000615
KBio3_000616
KBio3_001275
KBioGR_000308
KBioGR_001572
KBioSS_000308
KBioSS_001821
Klofelin
Klofenil
L000193
LS-79606
Lopac-C-7897
Lopac0_000268
M 5041T
M-5041T
MolPort-001-779-668
MolPort-005-932-374
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
NCGC00015268-01
NCGC00015268-02
NCGC00015268-08
NCGC00024734-01
NCGC00024734-02
NCGC00024734-03
NCGC00024734-04
NCGC00024734-05
NCGC00179680-01
NINDS_000774
Prestwick0_000248
Prestwick1_000248
Prestwick2_000248
Prestwick3_000248
SKF 34427
SPBio_001233
SPBio_002255
ST 155BS
ST-155-BS
ST-155BS
Spectrum2_001187
Spectrum3_000358
Spectrum4_000956
Spectrum5_000759
Spectrum_001341
T171
Tenso-Timelets
Tocris-0690
UNII-MN3L5RMN02
ZINC00896484
clonidine
nchembio.79-comp11
nchembio705-10
17
MethyldopaapprovedPhase 1, Phase 214555-30-638853
Synonyms:
(-)-3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Alanine Sesqui-Hydrate
(-)-a-methyldopa
(-)-alpha-methyldopa
(-)-methyldopa
(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid
(S)-(-)-a-methyldopa
(S)-(-)-alpha-Methyldopa
(S)-(-)-alpha-methyldopa
133161-54-3
1339-75-9
2-Methyl-3-(3,4-dihydroxyphenyl)alanine
3,4-Dihydroxy-2-methylphenylalanine (ACD/Name 4.0)
3-(3,4-DIHYDROXYPHENYL)-2-METHYL-L-ALANINE
3-Hydroxy-.alpha.-methyl-L-tyrosine
3-Hydroxy-alpha-methyl-L-tyrosine
4290-08-8
555-30-6
779-08-8
AC-11671
AC1L20K1
AC1Q29EL
AC1Q29EM
AMD
Aldoclor-150
Aldoclor-250
Aldomet
Aldomet (TN)
Aldometil
Aldomin
Aldoril 15
Aldoril 25
Aldoril D30
Aldoril D50
Aldoril, Dopamet, Dopegyt, Methyldopa
Alpha medopa
Alphamethyldopa
Anhydrous methyldopa
Apo Methyldopa Tab 125mg
Apo Methyldopa Tab 250mg
Apo Methyldopa Tab 500mg
Apo-Methyldopa
Apo-methyldopa
BIDD:GT0620
BPBio1_000365
BSPBio_000331
BSPBio_002021
Bayer 1440 L
Baypresol
Becanta
C07194
CCRIS 4671
CHEBI:61058
CHEMBL459
CID38853
D08205
DB00968
DivK1c_000142
Dopamet
Dopamethyperpax
Dopatec
Dopegit
Dopegyt
Dopergit
EINECS 209-089-2
EU-0100853
Grospisk
HMS1569A13
HMS1920N09
HMS2090B11
HMS2091F04
HMS500H04
HSDB 218
Hyperpax
Hypolag
IDI1_000142
KBio1_000142
KBio2_001417
KBio2_003985
KBio2_006553
KBio3_001521
KBioGR_000547
KBioSS_001417
L(-)-a-Methylalanine
L(-)-alpha-Methylalanine
L(-)-beta-(3,4-Dihydroxyphenyl)-alpha-methylalanine
L-(-)-3-(3,4-Dihydroxyphenyl)-2-methyl-Alanine
L-(-)-3-(3,4-Dihydroxyphenyl)-2-methylalanine
L-(-)-a-Methyl-a-methyl-Aldomin
L-(-)-alpha-Methyl-alpha-methyl-Aldomin
L-(-)-alpha-Methyl-beta-(3,4-dihydroxyphenyl)alanine
L-(a-MD)
L-(alpha-Md)
L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid
L-Methyl Dopa
L-Methyl dopa
 
L-Methyldopa
L-a-Methyl-(3, 4-dihydroxyphenyl)alanine
L-a-Methyldopa
L-alpha-Methyl DOPA
L-alpha-Methyl-(3, 4-dihydroxyphenyl)alanine
L-alpha-Methyl-3,4-dihydroxyphenylalanine
L-alpha-Methyldopa
LS-216
LT00847269
Lopac0_000853
METHYL DOPA (SEE ALSO METHYL DOPA SESQUIHYDRATE)
MK 351
MK-351
MLS000028644
Medomet
Medopa
Medopal
Medopren
Methoplain
Methyl dopa
Methyl-L-dopa
Methyldopa
Methyldopa (INN)
Methyldopa (L,-)
Methyldopa (anhydrous)
Methyldopa 125 Tab 125mg
Methyldopa 250 Tab
Methyldopa 500 Tab 500mg
Methyldopa anhydrous
Methyldopate
Methyldopate HCL
Methyldopum
Methyldopum [INN-Latin]
Metildopa
Metildopa [INN-Spanish]
Mk. b51
MolPort-001-792-485
NCGC00024667-01
NCGC00024667-02
NCGC00024667-03
NCGC00024667-05
NCGC00024667-06
NCGC00024667-08
NCI-C55721
NINDS_000142
NSC 169916
NSC169916
Novo-Medopa Tab 125mg
Novo-Medopa Tab 250mg
Novo-Medopa Tab 500mg
Novomedopa
Nr.C 2294
Nu-Medopa
Nu-Medopa Tab 125mg
Nu-Medopa Tab 250mg
Nu-Medopa Tab 500mg
Nu-medopa
Presinol
Presolisin
Prestwick0_000326
Prestwick1_000326
Prestwick2_000326
Prestwick3_000326
Prestwick_732
S1642_Selleck
SMR000059170
SPBio_001056
SPBio_002252
SPECTRUM1500403
Sedometil
Sembrina
Spectrum2_001068
Spectrum3_000501
Spectrum4_000054
Spectrum5_001295
Spectrum_000937
Tocris-0584
UNII-56LH93261Y
a-Methyl dopa
a-Methyl-L-3,4-dihydroxyphenylalanine
a-Methyl-L-dopa
a-Methyldopa (van)
alpha Medopa
alpha-Methyl dopa
alpha-Methyl-L-3,4-dihydroxyphenylalanine
alpha-Methyl-L-dopa
alpha-Methyl-beta-(3,4-dihydroxyphenyl)-L-alanine
alpha-Methyldihydroxyphenylalanine
alpha-Methyldopa
alpha-Methyldopa (VAN)
alpha-Methyldopa (van)
alpha-methyl-L-dopa
l-3-(3,4-Dihydroxyphenyl)-2-methylalanine
l-alpha-Methyldopa
levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine
α-Methyl dopa
α-methyl-L-dopa
18
NifedipineapprovedPhase 1, Phase 211221829-25-44485
Synonyms:
101539-70-2
101554-38-5
21829-25-4
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester
5-22-04-00268 (Beilstein Handbook Reference)
60299-11-8 (mono-hydrochloride)
AC-11618
AC1L1I9V
AC1Q4254
AKOS002942507
ARONIS24171
AWD Pharma Brand of Nifedipine
Adalat
Adalat (TN)
Adalat 10
Adalat 20
Adalat 5
Adalat CC
Adalat CR
Adalat Crono
Adalat FT
Adalat Ft
Adalat GITS
Adalat GITS 30
Adalat Gits
Adalat Gits 30
Adalat LA
Adalat LP
Adalat Oros
Adalat PA
Adalat Retard
Adalat XL
Adalate
Adalate LP
Adapine
Adapress
Adcock Ingram Brand of Nifedipine
Adipine XL
Afeditab
Afeditab CR
Afeditab CR (TN)
Alat
Aldipin
Alfadal
Alonix
Alonix S
Alpha-Nifedipine Retard
Angipec
Anifed
Anpine
Apo-Nifed
Aprical
Aprical long
BAY 1040
BAY A 1040
BAY-a 1040
BAYa1040
BCBcMAP01_000046
BIDD:GT0442
BIDD:PXR0034
BIM-0050796.0001
BPBio1_000271
BRN 0497773
BSPBio_000245
BSPBio_001391
BSPBio_002071
Bay-1040
Bay-a-1040
Bay1040
Bayer Brand of Nifedipine
Bio-0733
Bio1_000112
Bio1_000601
Bio1_001090
Bio2_000111
Bio2_000591
Bonacid
C07266
C17H18N2O6
CAS-21829-25-4
CBiol_001826
CCRIS 6074
CHEBI:7565
CHEMBL193
CID4485
CPD000058291
Calcibloc
Calcigard
Calcilat
Camont
Cardifen
Cardilat
Cardionorm
Chronadalate
Chronadalate LP
Chronadalate Lp
Citilat
Coracten
Coracten XL
Coral
Cordafen
Cordaflex
Cordalat
Cordicant
Cordilan
Cordipin
Cordipine
Corinfar
Corotrend
Corynphar
D00437
D009543
DB01115
Depin
Dignokonstant
Dilafed
Dilcor
Dipinkor
DivK1c_000313
Duranifin
EINECS 244-598-3
EU-0100819
Ecodipi
Ecodipin
Ecodipin E
Emaberin
Fedcor
Fedcor Retard
Fenamon
Fenamon SR
Fenamon Sr
Fenigidin
Fenihidin
Fenihidine
Fortipine LA
Glopir
HMS1361F13
HMS1568M07
HMS1791F13
HMS1920P19
HMS1989F13
HMS2051O03
HMS2089H11
HMS2091H20
 
HMS500P15
Hadipin
Hexadilat
I06-0051
I06-1286
IDI1_000313
IDI1_033861
Infedipin
Introcar
KB-1712P
KBio1_000313
KBio2_000111
KBio2_001459
KBio2_002400
KBio2_002679
KBio2_004027
KBio2_004968
KBio2_005247
KBio2_006595
KBio2_007536
KBio3_000221
KBio3_000222
KBio3_001571
KBio3_002879
KBioGR_000111
KBioGR_000627
KBioGR_002400
KBioSS_000111
KBioSS_001459
KBioSS_002405
KRKA Brand of Nifedipine
Kordafen
Korinfar
L001054
LS-1012
Lopac-N-7634
Lopac0_000819
MLS000028521
MLS000758222
MLS001148146
MLS001401371
Macorel
Megalat
MolPort-000-787-707
MolPort-006-822-492
Monohydrochloride, Nifedipine
Myogard
N 7634
N0528
N1fedilat
N7634_SIGMA
NCGC00015748-01
NCGC00015748-02
NCGC00015748-03
NCGC00015748-06
NCGC00015748-13
NCGC00024983-01
NCGC00024983-02
NCGC00024983-03
NCGC00024983-04
NCGC00024983-05
NCGC00024983-06
NCGC00024983-07
NCGC00024983-08
NCGC00091707-01
NINDS_000313
Nedipin
Nicardia
Nifangin
Nifar
Nifdemin
Nifebene
Nifecard
Nifecor
Nifedepat
Nifediac
Nifedical
Nifedical XL
Nifedicor
Nifedin
Nifedine
Nifedipine
Nifedipine (JP15/USP/INN)
Nifedipine Bayer Brand
Nifedipine GTIS
Nifedipine KRKA Brand
Nifedipine Monohydrochloride
Nifedipine Orion Brand
Nifedipine Pfizer Brand
Nifedipine Retard
Nifedipine [USAN:BAN:INN:JAN]
Nifedipine-GTIS
Nifedipino
Nifedipino [INN-Spanish]
Nifedipinum
Nifedipinum [INN-Latin]
Nifedipres
Nifedirex LP
Nifelan
Nifelat
Nifelat Q
Nifelate
Nifensar XL
Nificard
Nifidine
Nifipen
Niphedipine
Oprea1_788617
Orion Brand of Nifedipine
Orix
Oxcord
Pfizer Brand of Nifedipine
Pidilat
Prestwick0_000063
Prestwick1_000063
Prestwick2_000063
Prestwick3_000063
Prestwick_357
Procardia
Procardia (TN)
Procardia XL
S1808_Selleck
SAM001246963
SMR000058291
SPBio_001016
SPBio_002166
SPECTRUM1500431
STK735567
Sepamit
Slofedipine XL
Spectrum2_001058
Spectrum3_000516
Spectrum4_000074
Spectrum5_001278
Spectrum_000979
Tensipine MR
Tibricol
Tocris-1075
UNII-I9ZF7L6G2L
Vascard
ZINC19594578
Zenusin
cMAP_000042
nchembio.95-comp13
nifedipine
19Vasodilator AgentsPhase 1, Phase 23438
20SympatholyticsPhase 1, Phase 2555
21Adrenergic alpha-2 Receptor AgonistsPhase 1, Phase 2911
22Adrenergic alpha-AgonistsPhase 1, Phase 21625
23Adrenergic AgonistsPhase 1, Phase 22877
24Nicotinic AgonistsPhase 2902
25Central Nervous System StimulantsPhase 22132
26Cholinergic AgentsPhase 23846
27
Vareniclineapproved, investigational269249296-44-45310966
Synonyms:
249296-44-4
7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine
7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline
AC1L55H0
AC1Q4W6H
AKOS005145561
AR-1H2911
CHEBI:430452
CHEMBL1396
CID170361
CP 526555
 
CP-526,555
Champix
Chantix
D08669
HSDB 7591
I14-1963
LS-187375
UNII-W6HS99O8ZO
Varenicline
Varenicline (INN)
Varenicline tartrate
varenicline
28Serotonin Agents3102
29Serotonin Uptake Inhibitors1570
30Neurotransmitter Uptake Inhibitors3464
31Antibiotics, Antitubercular6972
32Anti-Bacterial Agents10884
33
Serotonin356650-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine

Interventional clinical trials:

(show all 36)
idNameStatusNCT IDPhase
1PRIDE: Preventing Respiratory Illnesses During Childhood StudyCompletedNCT00927264Phase 4
2Influence of Pacifiers on Breastfeeding DurationCompletedNCT00306956Phase 3
3Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia TrialWithdrawnNCT00293735Phase 2, Phase 3
4Treatment Targets for Chronic Hypertension in PregnancyUnknown statusNCT00194974Phase 1, Phase 2
5Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority SmokersCompletedNCT00341432Phase 2
6Is Home Positioning Time Associated With Torticollis Rate of Recovery?CompletedNCT00347334Phase 1
7Do Pacifiers Protect From Sudden Infant Death Syndrome (SIDS) Through an Increase in Upper Airway Patency?Unknown statusNCT01120938
8Validation of a Non Invasive Blood Marker of SIDS and Vagal DisordersUnknown statusNCT01358461
9Optimizing Technology-Delivered Interventions for Smoking in Pregnancy: The Mommy Check-Up Study.Unknown statusNCT02340624
10Factors Influencing the Racial Disparity in Sudden Infant Death Syndrome (SIDS)CompletedNCT01361893
11Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)CompletedNCT00004392
12Parental Knowledge and Beliefs About Infant Sleep PositionCompletedNCT00005567
13Study of the Impact of Parental Note Taking on the Effectiveness of Anticipatory GuidanceCompletedNCT01014169
14Magnetic Resonance Imaging Autopsy StudyCompletedNCT01417962
15Reduce African-American Infant MortalityCompletedNCT01361880
16Impact of Smoke-free Legislation on Early-life Mortality and Low Birth Weight in EnglandCompletedNCT02039583
17Characterization of Sweat Gland Function in Patients With Recessively Inherited Hypohidrotic Ectodermal DysplasiaCompletedNCT01109290
18Reducing Environmental Tobacco Smoke in Neonatal Intensive Care Unit (NICU) Infants' HomesCompletedNCT00670280
19Secondhand Smoke Exposure Reduction Among Young Children in ChinaCompletedNCT00995254
20"Anticipatory Guidance in the Nursery and Its Impact on Non-urgent Emergency Department Visits"CompletedNCT01859065
21Re-enforcing Safe Sleep Practices for Caregivers With Tangible IncentivesCompletedNCT02010450
22Assessing the Impact of Smoke-free Legislation on Perinatal Health in the NetherlandsCompletedNCT02189265
23Varenicline Pregnancy Cohort StudyCompletedNCT01290445
24Training Mothers of Infants in Infant Cardiopulmonary Resuscitation (CPR)CompletedNCT00570869
25Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden DeathCompletedNCT00004805
26Cardiac Autonomic Control in Children of HIV Positive MothersCompletedNCT00005353
27The Paediatric Virtual Autopsy TrialRecruitingNCT01888380
28Brainstem and PrematurityRecruitingNCT02669056
29Baby NAP SACC Intervention StudyRecruitingNCT01890681
30Effect of Antenatal SSRI Exposure on the QT Interval of NeonatesRecruitingNCT02492347
31Effects of Mother Position in Skin-to-skin Contact Newborn on Oxygen Saturation Levels.RecruitingNCT02585492
32Pilot Study of Novel Postpartum Educational Video InterventionActive, not recruitingNCT02267265
33Comparing Children's Book to Brochures for Safe Sleep Education in a Home Visiting ProgramEnrolling by invitationNCT02376673
34Is Gastroesophageal Reflux Really a Potential Risk for the Late Complications of Bronchopulmonary Dysplasia?Not yet recruitingNCT03014453
35Diagnostic Performance Comparison Between Procalcitonin-based vs. ANAES-based GuidelinesNot yet recruitingNCT02590198
36Changes in Sleep Patterns and Stress in Infants Entering Child CareSuspendedNCT01265277

Search NIH Clinical Center for Sudden Infant Death Syndrome


Cochrane evidence based reviews: sudden infant death

Genetic Tests for Sudden Infant Death Syndrome

About this section

Genetic tests related to Sudden Infant Death Syndrome:

id Genetic test Affiliating Genes
1 Sudden Infant Death Syndrome27

Anatomical Context for Sudden Infant Death Syndrome

About this section

MalaCards organs/tissues related to Sudden Infant Death Syndrome:

36
Brain, Skin, Heart, Lung, Hypothalamus, Testes, Liver

Publications for Sudden Infant Death Syndrome

About this section

Articles related to Sudden Infant Death Syndrome:

(show top 50)    (show all 650)
idTitleAuthorsYear
1
Post-mortem whole-exome analysis in a large sudden infant death syndrome cohort with a focus on cardiovascular and metabolic genetic diseases. (28074886)
2017
2
Swaddling and the Risk of Sudden Infant Death Syndrome: A Meta-analysis. (27244847)
2016
3
Promotion of the Unfolding Protein Response in Orexin/Dynorphin Neurons in Sudden Infant Death Syndrome (SIDS): Elevated pPERK and ATF4 Expression. (27796753)
2016
4
Perinatal Fluoxetine Exposure Impairs the CO2 Chemoreflex: Implications for Sudden Infant Death Syndrome. (27018763)
2016
5
The Disappearance of Sudden Infant Death Syndrome. (27571448)
2016
6
Impaired orexin receptor expression in the KAPlliker-Fuse nucleus in sudden infant death syndrome: possible involvement of this nucleus in arousal pathophysiology. (27353953)
2016
7
Synaptogenesis and Myelination in the Nucleus/Tractus Solitarius: Potential Role in Apnea of Prematurity, Congenital Central Hypoventilation, and Sudden Infant Death Syndrome. (26661483)
2016
8
Medullary mediation of the laryngeal adductor reflex: A possible role in sudden infant death syndrome. (26774498)
2016
9
The Disappearance of Sudden Infant Death Syndrome: Has the Clock Turned Back? (26833064)
2016
10
Sudden Infant Death Syndrome - Role of Trigeminocardiac Reflex: A Review. (27994573)
2016
11
Hypothesis on supine sleep, sudden infant death syndrome reduction and association with increasing autism incidence. (27610351)
2016
12
Sudden infant death syndrome: exposure to cigarette smoke leads to hypomethylation upstream of the growth factor independent 1 (GFI1) gene promoter. (27677632)
2016
13
A "Wear and Tear" Hypothesis to Explain Sudden Infant Death Syndrome. (27840622)
2016
14
Evolution and significance of the triple risk model in sudden infant death syndrome. (28028890)
2016
15
Inner ear lesion and the differential roles of hypoxia and hypercarbia in triggering active movements: Potential implication for the Sudden Infant Death Syndrome. (27634772)
2016
16
Metabolomic profiling of brain from infants who died from Sudden Infant Death Syndrome reveals novel predictive biomarkers. (27608295)
2016
17
Area-based study shows most parents follow advice to reduce risk of sudden infant death syndrome. (27992061)
2016
18
Risk Factors, Protective Factors, and Current Recommendations to Reduce Sudden Infant Death Syndrome: A Review. (27918760)
2016
19
The Disappearance of Sudden Infant Death Syndrome-Reply. (27571548)
2016
20
Nurses' Knowledge and Adherence To Sudden Infant Death Syndrome Prevention Guidelines. (27019936)
2016
21
Maternal and obstetrical predictors of sudden infant death syndrome (SIDS). (27734747)
2016
22
Environmental risk factors for sudden infant death syndrome in Japan. (27664161)
2016
23
Sudden infant death syndrome caused by cardiac arrhythmias: only a matter of genes encoding ion channels? (26872470)
2016
24
Sudden infant death syndrome: no significant expression of heat-shock proteins (HSP27, HSP70). (26662848)
2016
25
Aspiring to inspire - serotonin, the laryngeal chemoreflex and the sudden infant death syndrome. (27368108)
2016
26
Altered gene expression and possible immunodeficiency in cases of sudden infant death syndrome. (26959483)
2016
27
Proteomic MALDI-TOF/TOF-IMS examination of peptide expression in the formalin fixed brainstem and changes in sudden infant death syndrome infants. (26926438)
2016
28
Candidate gene variants of the immune system and sudden infant death syndrome. (26975745)
2016
29
Comment on Fard et al.'s Candidate gene variants of the immune system and sudden infant death syndrome. (27188625)
2016
30
Animal models for assessment of infection and inflammation: contributions to elucidating the pathophysiology of sudden infant death syndrome. (25870597)
2015
31
Undiagnosed metabolic dysfunction and sudden infant death syndrome--a case-control study. (25689231)
2015
32
Escherichia coli and Sudden Infant Death Syndrome. (26191064)
2015
33
Sudden infant death syndrome. (26034855)
2015
34
Association between sudden infant death syndrome and diphtheria-tetanus-pertussis immunisation: an ecological study. (25626628)
2015
35
Prenatal-perinatal Nicotine Alters Neonatal Raphe Neurons: Meaning for Sudden Infant Death Syndrome. (25695895)
2015
36
The role of the sodium current complex in a nonreferred nationwide cohort of sudden infant death syndrome. (25757662)
2015
37
Sudden infant death syndrome and residential altitude. (26009621)
2015
38
Genetic and Environmental Factors Affecting TNF-I+ Responses in Relation to Sudden Infant Death Syndrome. (26284064)
2015
39
A note on the prevalence of cardiac ion channelopathies in the sudden infant death syndrome. (26056187)
2015
40
Breastfeeding and dummy use have a protective effect on sudden infant death syndrome. (26175065)
2015
41
A New Theory to Explain the Underlying Pathogenetic Mechanism of Sudden Infant Death Syndrome. (26539157)
2015
42
Potential Central Nervous System Involvement in Sudden Unexpected Infant Deaths and the Sudden Infant Death Syndrome. (26140709)
2015
43
Microglia modulate brainstem serotonergic expression following neonatal sustained hypoxia exposure: implications for Sudden Infant Death Syndrome. (26659585)
2015
44
Polymorphisms in genes of respiratory control and sudden infant death syndrome. (26198620)
2015
45
Ignored Disease or Diagnostic Dustbin? Sudden Infant Death Syndrome in the British Context. (26217070)
2015
46
Decreased orexin (hypocretin) immunoreactivity in the hypothalamus and pontine nuclei in sudden infant death syndrome. (25953524)
2015
47
Sudden infant death syndrome and abnormal metabolism of thiamin. (26455416)
2015
48
Incidence and determinants of sudden infant death syndrome: a population-based study on 37 million births. (25447630)
2015
49
Evidence for Infection and Inflammation in Infant Deaths in a Country with Historically Low Incidences of Sudden Infant Death Syndrome. (26379661)
2015
50
Sudden infant death syndrome and the genetics of inflammation. (25750641)
2015

Variations for Sudden Infant Death Syndrome

About this section

UniProtKB/Swiss-Prot genetic disease variations for Sudden Infant Death Syndrome:

70 (show all 11)
id Symbol AA change Variation ID SNP ID
1CAV3p.Val14LeuVAR_043694rs121909281
2CAV3p.Thr78MetVAR_043695rs72546668
3CAV3p.Leu79ArgVAR_043696rs121909282
4GPD1Lp.Glu83LysVAR_044044rs72552292
5GPD1Lp.Ile124ValVAR_044045rs72552293
6GPD1Lp.Arg273CysVAR_044046rs72552294
7KCNJ8p.Val346IleVAR_065879rs147316959
8SCN5Ap.Ser1333TyrVAR_036666rs199473604
9SCN5Ap.Phe532CysVAR_055177rs199473573
10SCN5Ap.Gly1084SerVAR_055185rs199473190
11SCN5Ap.Phe1705SerVAR_055207rs199473627

Clinvar genetic disease variations for Sudden Infant Death Syndrome:

5
id Gene Variation Type Significance SNP ID Assembly Location
1SCN4BNM_174934.3(SCN4B): c.617C> T (p.Ser206Leu)SNVLikely pathogenicrs140348243GRCh38Chr 11, 118137097: 118137097
2KCNQ1NM_000218.2(KCNQ1): c.1135T> C (p.Trp379Arg)SNVPathogenicrs199472768GRCh37Chr 11, 2608806: 2608806
3KCNQ1NM_000218.2(KCNQ1): c.820A> G (p.Ile274Val)SNVLikely pathogenic, Pathogenicrs199472728GRCh37Chr 11, 2594115: 2594115
4KCNH2NM_000238.3(KCNH2): c.2860C> T (p.Arg954Cys)SNVPathogenicrs141401803GRCh37Chr 7, 150644799: 150644799
5SCN5ANM_000335.4(SCN5A): c.5474G> A (p.Arg1825His)SNVLikely pathogenic, Pathogenicrs137854610GRCh37Chr 3, 38592386: 38592386
6MT-TL1m.3290T> CSNVPathogenicrs199474665GRCh37Chr MT, 3290: 3290
7MT-ND1m.3308T> CSNVPathogenicrs28358582GRCh37Chr MT, 3308: 3308
8MT-ND1m.3308T> GSNVPathogenicrs28358582GRCh37Chr MT, 3308: 3308

Expression for genes affiliated with Sudden Infant Death Syndrome

About this section
Search GEO for disease gene expression data for Sudden Infant Death Syndrome.

Pathways for genes affiliated with Sudden Infant Death Syndrome

About this section

GO Terms for genes affiliated with Sudden Infant Death Syndrome

About this section

Cellular components related to Sudden Infant Death Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1sarcolemmaGO:004238310.6CAV3, KCNJ8, SCN5A, SNTA1
2voltage-gated potassium channel complexGO:000807610.4KCNH2, KCNJ8, KCNQ1
3voltage-gated sodium channel complexGO:000151810.2SCN2B, SCN5A

Biological processes related to Sudden Infant Death Syndrome according to GeneCards Suite gene sharing:

(show all 29)
idNameGO IDScoreTop Affiliating Genes
1brainstem developmentGO:000336010.9PHOX2B, SCN5A
2cardiac muscle cell action potential involved in contractionGO:008600210.9SCN2B, SCN5A
3positive regulation of sodium ion transportGO:001076510.9GPD1L, SCN5A
4membrane repolarization during action potentialGO:008601110.9KCNH2, KCNQ1
5membrane depolarization during cardiac muscle cell action potentialGO:008601210.9SCN2B, SCN5A
6membrane repolarization during cardiac muscle cell action potentialGO:008601310.9KCNH2, KCNQ1
7membrane repolarization during ventricular cardiac muscle cell action potentialGO:009891510.9KCNH2, KCNQ1
8negative regulation of potassium ion transmembrane transportGO:190138010.9CAV3, KCNH2
9regulation of atrial cardiac muscle cell membrane repolarizationGO:006037210.9KCNQ1, SCN5A
10positive regulation of potassium ion transmembrane transportGO:190138110.9KCNH2, KCNQ1
11potassium ion exportGO:007143510.9KCNH2, KCNQ1
12potassium ion export across plasma membraneGO:009762310.8KCNH2, KCNQ1
13regulation of atrial cardiac muscle cell membrane depolarizationGO:006037110.8SCN2B, SCN5A
14cardiac conductionGO:006133710.8KCNH2, KCNQ1, SCN5A
15regulation of membrane repolarizationGO:006030610.8KCNH2, KCNQ1
16regulation of sodium ion transmembrane transportGO:190230510.8SCN5A, SNTA1
17cellular response to drugGO:003569010.7KCNH2, KCNQ1, TH
18regulation of ventricular cardiac muscle cell membrane depolarizationGO:006037310.7CAV3, GPD1L, SCN5A
19regulation of heart contractionGO:000801610.7CAV3, KCNQ1, TH
20cardiac muscle contractionGO:006004810.7KCNH2, KCNQ1, SCN2B, SCN5A
21response to pyrethroidGO:004668410.6SCN2B, TH
22regulation of sodium ion transmembrane transporter activityGO:200064910.6CAV3, GPD1L, SCN2B
23regulation of postsynaptic membrane potentialGO:006007810.6ADCYAP1, SCN2B, SCN5A
24memoryGO:000761310.6CHAT, SLC6A4, TH
25regulation of heart rateGO:000202710.6CAV3, GPD1L, SCN5A, SNTA1
26regulation of heart rate by cardiac conductionGO:008609110.6KCNH2, KCNQ1, SCN2B, SCN5A
27regulation of ventricular cardiac muscle cell membrane repolarizationGO:006030710.4CAV3, KCNH2, KCNQ1, SCN5A, SNTA1
28social behaviorGO:003517610.3EN1, SLC6A4, TH
29ventricular cardiac muscle cell action potentialGO:00860059.8CAV3, GPD1L, KCNH2, KCNQ1, SCN5A, SNTA1

Molecular functions related to Sudden Infant Death Syndrome according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1inward rectifier potassium channel activityGO:000524210.9KCNH2, KCNJ8
2voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarizationGO:008600810.6KCNH2, KCNQ1
3scaffold protein bindingGO:009711010.6KCNH2, KCNQ1, SCN5A
4voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarizationGO:190228210.6KCNH2, KCNQ1
5nitric-oxide synthase bindingGO:005099810.6CAV3, SCN5A, SLC6A4, SNTA1
6ion channel bindingGO:004432510.5CAV3, GPD1L, KCNQ1, SCN5A, SNTA1
7sodium channel regulator activityGO:001708010.4CAV3, GPD1L, SCN2B, SNTA1
8voltage-gated sodium channel activityGO:000524810.4SCN2B, SCN5A
9voltage-gated sodium channel activity involved in cardiac muscle cell action potentialGO:008600610.2SCN2B, SCN5A

Sources for Sudden Infant Death Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet